Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 1,087 -1.63%
18 Sep - close price
anupamrasayan.com BSE: 543275 NSE: ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Business Verticals FY24
1) Life Science Specialty Chemicals (91%):
a. Agrochemicals (65%)- Manufactures agro intermediates and agro active ingredients (insecticides, fungicides, and herbicides) for the agrochemical industry.
b. Personal Care (17%) - Manufactures antibacterial and ultraviolet protection intermediates and ingredients for the personal care industry.
c. Pharmaceuticals (9%)- The segment focuses on developing intermediates and ‘key starting materials’ for active pharmaceutical ingredients.

Website BSE NSE
  • Market Cap ₹ 12,331 Cr.
  • Current Price ₹ 1,087
  • High / Low ₹ 1,197 / 601
  • Stock P/E 122
  • Book Value ₹ 255
  • Dividend Yield 0.07 %
  • ROCE 4.73 %
  • ROE 2.62 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 4.26 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -2.11%
  • The company has delivered a poor sales growth of 11.1% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 4.82% over last 3 years.
  • Dividend payout has been low at 13.0% of profits over last 3 years
  • Company has high debtors of 266 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE 500 BSE SmallCap BSE Allcap BSE Commodities BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
310 314 296 371 288 317 215 308 164 191 212 331 316
213 219 206 279 210 226 151 235 127 139 140 225 221
Operating Profit 97 95 89 92 78 91 64 74 37 52 72 106 94
OPM % 31% 30% 30% 25% 27% 29% 30% 24% 22% 27% 34% 32% 30%
-13 -5 -4 18 10 4 1 11 6 4 -3 5 5
Interest 12 16 14 20 18 20 25 25 22 25 30 29 34
Depreciation 16 16 17 17 17 18 18 18 19 20 26 27 26
Profit before tax 57 58 54 74 54 57 22 42 2 11 13 55 39
Tax % 34% 29% 29% 30% 35% 32% 29% 32% 30% -29% -47% 31% 24%
37 41 39 51 35 39 15 28 1 14 19 38 30
EPS in Rs 3.73 4.11 3.61 4.77 3.24 3.60 1.40 2.58 0.13 1.28 1.74 3.46 2.70
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
228 273 288 288 343 502 529 811 1,074 1,284 1,129 896 1,049
179 204 208 218 269 408 394 618 770 917 822 631 725
Operating Profit 49 69 80 70 73 93 134 193 304 367 307 265 324
OPM % 22% 25% 28% 24% 21% 19% 25% 24% 28% 29% 27% 30% 31%
2 5 8 11 6 19 11 26 7 2 26 13 11
Interest 22 14 21 21 15 24 45 69 31 62 87 107 119
Depreciation 5 10 13 15 18 23 29 52 60 66 72 91 99
Profit before tax 24 50 54 45 48 66 71 99 220 242 174 81 118
Tax % 23% 28% 21% 22% 19% 24% 26% 30% 32% 30% 32% 10%
18 36 43 35 39 50 53 70 151 169 117 73 101
EPS in Rs 18.45 7.27 8.53 6.96 7.73 10.05 10.60 7.00 15.04 15.69 10.69 6.61 9.18
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 7% 7% 16% 12% 11%
Compounded Sales Growth
10 Years: 13%
5 Years: 11%
3 Years: -6%
TTM: 4%
Compounded Profit Growth
10 Years: 7%
5 Years: 7%
3 Years: -22%
TTM: 20%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 14%
1 Year: 43%
Return on Equity
10 Years: 7%
5 Years: 6%
3 Years: 5%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 10 50 50 50 50 50 50 100 100 107 110 110
Reserves 61 58 97 194 382 432 515 1,473 1,624 2,252 2,627 2,695
117 144 279 318 449 687 846 423 836 822 1,067 1,323
29 51 55 70 97 145 252 300 325 388 547 752
Total Liabilities 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,351 4,881
90 145 259 313 379 682 978 1,116 1,203 1,240 1,277 1,849
CWIP 1 21 64 88 250 183 101 42 43 113 579 206
Investments 0 2 2 2 2 0 0 0 148 158 159 159
126 134 157 230 347 449 583 1,137 1,492 2,057 2,336 2,667
Total Assets 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,351 4,881

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
51 68 69 17 -8 42 95 1 -171 244 22 -65
-38 -88 -168 -93 -247 -261 -178 -192 -412 -478 -362 -286
11 9 100 73 254 209 102 416 384 376 398 192
Net Cash Flow 24 -10 0 -3 -0 -9 19 224 -199 142 58 -160

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 48 36 28 71 94 88 89 92 95 106 176 266
Inventory Days 153 158 211 305 411 277 513 528 849 626 849 1,553
Days Payable 56 92 94 156 148 105 225 213 223 202 332 631
Cash Conversion Cycle 144 101 144 220 358 260 378 407 721 530 692 1,188
Working Capital Days 120 86 113 79 88 55 21 168 222 177 162 218
ROCE % 29% 22% 13% 9% 9% 9% 10% 11% 11% 7% 5%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Jul 2025
60.96% 60.80% 60.77% 60.73% 61.41% 61.26% 61.23% 61.23% 61.19% 61.19% 61.19% 59.07%
8.19% 8.52% 9.79% 10.26% 9.13% 8.07% 7.14% 7.00% 7.46% 6.47% 4.94% 7.76%
6.18% 4.98% 3.74% 1.76% 2.51% 2.56% 2.56% 2.30% 2.32% 2.25% 2.24% 2.11%
24.67% 25.68% 25.71% 27.25% 26.96% 28.10% 29.06% 29.47% 29.06% 30.11% 31.65% 31.05%
No. of Shareholders 73,32666,50761,50461,12960,08957,62362,21863,86660,93857,47847,71148,524

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls